APH
61
-6
UHS
54
3
V
42
6
AMG
79
2
SLG
45
7
CHD
35
3
CINF
48
3
GE
68
-9
CMG
37
2
EL
53
3
LEN
57
2
LLY
53
3
PSA
40
3
WHR
53
7
NAVI
29
5
MAS
82
4
FRT
56
5
UNH
33
4
AON
71
6
ITW
46
4
APH
61
-6
UHS
54
3
V
42
6
AMG
79
2
SLG
45
7
CHD
35
3
CINF
48
3
GE
68
-9
CMG
37
2
EL
53
3
LEN
57
2
LLY
53
3
PSA
40
3
WHR
53
7
NAVI
29
5
MAS
82
4
FRT
56
5
UNH
33
4
AON
71
6
ITW
46
4
Financhill
Back

Simplify Opportunistic Income ETF Vs. CRISPR Therapeutics AG Sector Stock Comparison

Buy
52

CRDT
Simplify Opportunistic Income ETF

Last Price:
$24.13
Seasonality Move:
-0.73%
Sell
45

CRSP
CRISPR Therapeutics AG

Last Price:
$58.82
Seasonality Move:
-4.74%
Buy
52
Simplify Opportunistic Income ETF (CRDT) is a Buy

Is Simplify Opportunistic Income ETF a Buy, Sell or Hold?

  • The current Simplify Opportunistic Income ETF [CRDT] share price is $24.15. The Score for CRDT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CRDT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $57.33. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRDT Stock Price Chart

What is Simplify Opportunistic Income ETF's stock price today?

  • The Simplify Opportunistic Income ETF share price today is $24.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDT is experiencing slight buying pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $57.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

CRDT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.32 Buy
Relative Strength Index (14 RSI): 54.52 Buy
Chaikin Money Flow: 916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.93 - 24.09) Buy
Bollinger Bands (100): (24.04 - 25.18) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 14.76 Buy
Relative Strength Index (14 RSI): 52.15 Buy
Chaikin Money Flow: -5739107 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.63 - 63.39) Sell
Bollinger Bands (100): (34.88 - 54.44) Buy

CRDT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.07 Buy
20-day SMA: 24.02 Buy
50-day SMA: 24.15 Buy
200-day SMA: 24.96 Sell
8-day EMA: 22.89 Buy
20-day EMA: 16.81 Buy
50-day EMA: 9.16 Buy
200-day EMA: 2.72 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.48 Buy
20-day SMA: 59.75 Sell
50-day SMA: 52.31 Buy
200-day SMA: 44.84 Buy
8-day EMA: 53.69 Buy
20-day EMA: 39.55 Buy
50-day EMA: 21.6 Buy
200-day EMA: 6.41 Buy

Simplify Opportunistic Income ETF Earnings Growth & CRDT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.90 per share, and an increase next year of $1.35 per share.

Simplify Opportunistic Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):